As used in this subpart:

1. (1) “Chronic nonmalignant pain” means pain requiring more than three (3) consecutive months of prescriptions for:

   1. (A) An opioid that is written for more than the equivalent of ninety (90) tablets, each containing five milligrams (5mg) of hydrocodone;
   2. (B) A morphine equivalent dose of more than fifteen milligrams (15mg) per day; or
   3. (C) In the specific case of tramadol, a dose of fifty milligrams (50mg) per one hundred twenty (120) tablets;
2. (2) “Chronic pain management program” provides coordinated, goal-oriented, interdisciplinary team services to reduce pain, improve functioning, and decrease the dependence on the healthcare system of persons with chronic pain syndrome;

3. (3) “Chronic pain syndrome” means any set of verbal and/or nonverbal behaviors that:

   1. (A) Involves the complaint of enduring pain;
   2. (B) Differs significantly from a person's premorbid status;
   3. (C) Has not responded to previous appropriate medical and/or surgical treatment; and
   4. (D) Interferes with a person's physical, psychological, and social and/or vocational functioning;

4. (4) “Opioid” means a drug or medication that relieves pain, including without limitation:

   1. (A) Hydrocodone;
   2. (B) Oxycodone;
   3. (C) Morphine;
   4. (D) Codeine;
   5. (E) Heroin; and
   6. (F) Fentanyl; and
5. (5) “Prescriber” means a practitioner or other authorized person who prescribes a Schedule II, III, IV, or V controlled substance.